Concepedia

Hormone receptor and HER2 assessment in breast carcinoma metastatic to bone: A comparison between FNA cell blocks and decalcified core needle biopsies

Jennifer Zeng, Salvatore Piscuoglio, Gitika Aggarwal, Joanna Magda, Maria A. Friedlander, Melissa P. Murray, Muzaffar Akram, Jorge S. Reis‐Filho, Britta Weigelt, Marcia Edelweiss

Cancer Cytopathology · 2019 · 10 citations · 42 references

DOIFull text

Open access

Abstract

FNA-CB and CNB appear to constitute acceptable methods for the assessment of ER, PR, and HER2 for clinical decision making.

References

42

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Journal of Clinical Oncology · 2006 · 4.5K citations

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

M. Elizabeth H. Hammond, Daniel F. Hayes, Mitch Dowsett et al. · Journal of Clinical Oncology · 2010 · 4.2K citations · Full text

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks et al. · Journal of Clinical Oncology · 2013 · 4K citations · Full text

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

Sohrab P. Shah, Ryan D. Morin, Jaswinder Khattra et al. · Nature · 2009 · 1.1K citations · Full text

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

Pedram Razavi, Matthew T. Chang, Guotai Xu et al. · Cancer Cell · 2018 · 956 citations · Full text

, , +3